Explore All Access
Check if your research matches the topics covered in In Vivo?
- Degree of match
- Common matching concepts
- Additional journal recommendations
In Vivo : Impact Factor & More
eISSN: 1791-7549pISSN: 0258-851X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
In Vivo Key Metrics
CiteScore 
3.1
Impact Factor
< 5
SJR
Q4Pharmacology
SNIP
0.84
Topics Covered on In Vivo
Cancer
Overall survival
Amino acid
Lung cancer
Sarcopenia
Lymph node
Neurofibromatosis
Chemoradiotherapy
Genotype
Hepatocellular carcinoma
Cerebral cortex
Breast cancer
Irradiation
Partial response
Thrombotic microangiopathy
Lung
Surgery
Reactive oxygen species
Adjuvant
Osteoid osteoma
In Vivo Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in In Vivo ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in In Vivo
The Role of Radiotherapy for Meningeal Melanocytomas - A 20 Year Update.
- 1 Jan 2024
- In vivo (Athens, Greece)
The Impact of PM2.5 on Radiation-induced Pneumonitis in Patients With Breast Cancer.
- 1 Jan 2024
- In vivo (Athens, Greece)
Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma.
- 1 Jan 2024
- In vivo (Athens, Greece)
Exosome Secretion and Cellular Signaling Change in a Fabry Disease Cell Model Induced by Gene-silencing.
- 1 Jan 2024
- In vivo (Athens, Greece)
Severe Burn Injuries - The Day the Sodium Starts Rising.
- 1 Jan 2024
- In vivo (Athens, Greece)
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.
- 1 Jan 2024
- In vivo (Athens, Greece)
The Role of Radiotherapy for Meningeal Melanocytomas - A 20 Year Update.
- 1 Jan 2024
- In vivo (Athens, Greece)
The Impact of PM2.5 on Radiation-induced Pneumonitis in Patients With Breast Cancer.
- 1 Jan 2024
- In vivo (Athens, Greece)
Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma.
- 1 Jan 2024
- In vivo (Athens, Greece)
Exosome Secretion and Cellular Signaling Change in a Fabry Disease Cell Model Induced by Gene-silencing.
- 1 Jan 2024
- In vivo (Athens, Greece)
Severe Burn Injuries - The Day the Sodium Starts Rising.
- 1 Jan 2024
- In vivo (Athens, Greece)
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.
- 1 Jan 2024
- In vivo (Athens, Greece)
Compare Similar Journals with In Vivo
Select Journals to Compare with In Vivo
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Medicine
Publisher: Elsevier
Cancers
Publisher: MDPI
Annals of Oncology
Publisher: ELSEVIER
BMC Cancer
Publisher: BMC
Scientific Reports
Publisher: NATURE PORTFOLIO
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Oncotarget
Publisher: Impact Journals
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
In Vivo
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on In Vivo
How long has In Vivo been actively publishing? 
In Vivo has been in operation since 1987 till date.
What is the publishing frequency of In Vivo?
In Vivo published with a Bi-monthly frequency.
How many articles did In Vivo publish last year?
In 2023, In Vivo publsihed 421 articles.
What is the eISSN & pISSN for In Vivo?
For In Vivo, eISSN is 1791-7549 and pISSN is 0258-851X.
What is Citescore for In Vivo?
Citescore for In Vivo is 3.1.
What is SNIP score for In Vivo?
SNIP score for In Vivo is 0.84.
What is the SJR for In Vivo?
SJR for In Vivo is Q4.
Who is the publisher of In Vivo?
INT INST ANTICANCER RESEARCH is the publisher of In Vivo.
